Massive sarcoma study reveals Real-World treatment patterns

NCT ID NCT03977818

Completed Knowledge-focused Sponsor: Institut Bergonié Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looked back at medical records of over 2,100 patients with metastatic soft tissue sarcoma treated in France between 1990 and 2013. Researchers analyzed which treatments patients received, including chemotherapy and local therapies, and how long they lived. The goal is to identify patterns that can improve care and guide future clinical trials for this rare cancer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors understand which treatments work best for different types of metastatic sarcoma, leading to better care guidelines.
What could go wrong: This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may be influenced by changes in treatment over the long study period (1990-2013).

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metastatic neoplasm Neoplasm Metastasis sarcoma soft tissue sarcoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHEMOTHERAPY METASTASES SARCOMA

Contacts and locations

Locations

Centre Léon Bérard, Comprehensive Cancer Center

Lyon, France
Institut Bergonié, Comprehensive Cancer Center

Bordeaux, France
Institut Gustave Roussy, Comprehensive Cancer Center

Villejuif, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.